- Home
- REPL vs VMO Comparison
REPL vs VMO Comparison
Compare REPL & VMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- REPL
- VMO
- Stock Information
- Founded
- REPL 2015
- VMO 1992
- Country
- REPL United States
- VMO United States
- Employees
- REPL N/A
- VMO N/A
- Industry
- REPL Biotechnology: Pharmaceutical Preparations
- VMO Trusts Except Educational Religious and Charitable
- Sector
- REPL Health Care
- VMO Finance
- Exchange
- REPL Nasdaq
- VMO Nasdaq
- Market Cap
- REPL 816.4M
- VMO 687.9M
- IPO Year
- REPL 2018
- VMO N/A
- Fundamental
- Price
- REPL $11.05
- VMO $9.86
- Analyst Decision
- REPL Strong Buy
- VMO
- Analyst Count
- REPL 4
- VMO 0
- Target Price
- REPL $17.00
- VMO N/A
- AVG Volume (30 Days)
- REPL 488.6K
- VMO 254.7K
- Earning Date
- REPL 11-12-2024
- VMO 01-01-0001
- Dividend Yield
- REPL N/A
- VMO 4.39%
- EPS Growth
- REPL N/A
- VMO N/A
- EPS
- REPL N/A
- VMO N/A
- Revenue
- REPL N/A
- VMO N/A
- Revenue This Year
- REPL N/A
- VMO N/A
- Revenue Next Year
- REPL $469.74
- VMO N/A
- P/E Ratio
- REPL N/A
- VMO N/A
- Revenue Growth
- REPL N/A
- VMO N/A
- 52 Week Low
- REPL $4.92
- VMO $7.86
- 52 Week High
- REPL $12.97
- VMO $9.87
- Technical
- Relative Strength Index (RSI)
- REPL 43.04
- VMO 42.83
- Support Level
- REPL $10.57
- VMO $9.85
- Resistance Level
- REPL $12.73
- VMO $9.98
- Average True Range (ATR)
- REPL 0.67
- VMO 0.08
- MACD
- REPL -0.16
- VMO 0.00
- Stochastic Oscillator
- REPL 20.00
- VMO 21.74
About REPL Replimune Group Inc.
Replimune Group Inc is a clinical-stage biotechnology company. It uses a proprietary RPx platform to design and develop product candidates that are intended to maximally activate the immune system against solid tumors. The RPx platform is based on a proprietary, engineered strain of herpes simplex virus 1, or HSV-1, backbone with payloads added to maximize immunogenic cell death and the induction of a systemic anti-tumor immune response. The company focuses on developing oncolytic immunotherapies for the treatment of cancer. Its pipeline products include RP1, RP2, and RP3.
About VMO Invesco Municipal Opportunity Trust
Invesco Municipal Opportunity Trust is a diversified, closed-end management investment company. The investment objective of the company is to provide common shareholders with a high level of current income exempt from federal income tax, consistent with preservation of capital.